Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$757M |
| 2 |
Microsoft
MSFT
|
+$725M |
| 3 |
Apple
AAPL
|
+$628M |
| 4 |
Amazon
AMZN
|
+$487M |
| 5 |
Meta Platforms (Facebook)
META
|
+$355M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$121M |
| 2 |
KE Holdings
BEKE
|
+$31.8M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$24.4M |
| 4 |
X
US Steel
X
|
+$18.4M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$15.6M |
Sector Composition
| 1 | Technology | 34.97% |
| 2 | Consumer Discretionary | 11.79% |
| 3 | Communication Services | 10.31% |
| 4 | Healthcare | 9.95% |
| 5 | Industrials | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1501
IPG Photonics
IPGP
$3.38B
| $3.36M | ﹤0.01% |
49,000
-1,300
| -3% | -$89.2K |
|
1502
Horace Mann Educators
HMN
$1.94B
| $3.36M | ﹤0.01% |
78,200
-800
| -1% | -$34.4K |
|
1503
Sunrun
RUN
$3.71B
| $3.36M | ﹤0.01% |
410,600
-24,100
| -6% | -$197K |
|
1504
Customers Bancorp
CUBI
$2.32B
| $3.35M | ﹤0.01% |
57,100
-600
| -1% | -$35.2K |
|
1505
Minerals Technologies
MTX
$1.99B
| $3.35M | ﹤0.01% |
60,800
-1,000
| -2% | -$55.1K |
|
1506
Gibraltar Industries
ROCK
$1.78B
| $3.35M | ﹤0.01% |
56,700
-2,100
| -4% | -$124K |
|
1507
Newmark Group
NMRK
$3.41B
| $3.33M | ﹤0.01% |
273,807
-1,900
| -0.7% | -$23.1K |
|
1508
Levi Strauss
LEVI
$8.67B
| $3.32M | ﹤0.01% |
179,800
-2,800
| -2% | -$51.8K |
|
1509
Steven Madden
SHOO
$2.26B
| $3.32M | ﹤0.01% |
138,625
-1,300
| -0.9% | -$31.2K |
|
1510
Upwork
UPWK
$2.24B
| $3.32M | ﹤0.01% |
247,000
| – | – |
|
1511
Sotera Health
SHC
$4.56B
| $3.32M | ﹤0.01% |
298,400
-3,400
| -1% | -$37.8K |
|
1512
Arlo Technologies
ARLO
$1.82B
| $3.32M | ﹤0.01% |
195,600
+1,200
| +0.6% | +$20.4K |
|
1513
Arrowhead Research
ARWR
$4.11B
| $3.31M | ﹤0.01% |
209,800
-7,100
| -3% | -$112K |
|
1514
Cellebrite
CLBT
$4.11B
| $3.31M | ﹤0.01% |
207,100
+15,800
| +8% | +$253K |
|
1515
Sylvamo
SLVM
$1.75B
| $3.31M | ﹤0.01% |
66,100
-1,500
| -2% | -$75.2K |
|
1516
National Vision
EYE
$1.82B
| $3.29M | ﹤0.01% |
142,900
-9,700
| -6% | -$223K |
|
1517
Huntsman Corp
HUN
$1.89B
| $3.29M | ﹤0.01% |
315,474
-2,900
| -0.9% | -$30.2K |
|
1518
Nelnet
NNI
$4.46B
| $3.27M | ﹤0.01% |
27,000
-300
| -1% | -$36.3K |
|
1519
Chemours
CC
$2.51B
| $3.27M | ﹤0.01% |
285,600
-3,900
| -1% | -$44.7K |
|
1520
Constellium
CSTM
$2.08B
| $3.27M | ﹤0.01% |
+245,700
| New | +$3.27M |
|
1521
CommScope
COMM
$3.61B
| $3.25M | ﹤0.01% |
393,100
-25,200
| -6% | -$209K |
|
1522
AvidXchange
AVDX
$2.06B
| $3.25M | ﹤0.01% |
332,100
-6,700
| -2% | -$65.6K |
|
1523
Surgery Partners
SGRY
$2.8B
| $3.25M | ﹤0.01% |
146,200
+10,700
| +8% | +$238K |
|
1524
Kymera Therapeutics
KYMR
$3.36B
| $3.25M | ﹤0.01% |
74,400
-900
| -1% | -$39.3K |
|
1525
Werner Enterprises
WERN
$1.68B
| $3.24M | ﹤0.01% |
118,300
-1,500
| -1% | -$41K |
|